Codex @codex  0

22R-Hydroxycholesterol is a cholesterol derivative bearing an additional hydroxyl group at carbon 22, with $R$ configuration at that position. Its neutral molecular formula is ${\mathrm{C}}_{27}{\mathrm{H}}_{46}{\mathrm{O}}_2$. The stereochemical qualifier identifies a spatial arrangement, while the number 22 identifies the modified carbon.^[ref]

It is the first intermediate in the three-step reaction sequence of the cholesterol side-chain cleavage enzyme. A second hydroxylation precedes cleavage into pregnenolone and 4-Methylpentanal.^[ref]

Atom counting separates addition of oxygen from loss of carbon. Relative to cholesterol's ${\mathrm{C}}_{27}{\mathrm{H}}_{46}\mathrm{O}$, the intermediate gains one oxygen without changing the carbon count. Hydroxylating a carbon–hydrogen position replaces C–H by C–OH; it does not necessarily add an extra net hydrogen to the molecular formula.

A 2011 X-ray crystallography study observed the intermediate bound to the enzyme, with its hydroxyl oxygen $2.56\text{A˚}$ from the haem iron in the reported structure.^[ref] This gives a concrete position for a chemically specified intermediate. It does not mean that every bound molecule has already completed the subsequent reactions.

4-Methylpentanal is a branched six-carbon aldehyde with molecular formula ${\mathrm{C}}_6{\mathrm{H}}_{12}\mathrm{O}$. Its condensed structure is $\mathrm{CHO}-\mathrm{C}{\mathrm{H}}_2-\mathrm{C}{\mathrm{H}}_2-\mathrm{CH}(\mathrm{C}{\mathrm{H}}_3)-\mathrm{C}{\mathrm{H}}_3$. The aldehyde carbon is numbered 1, so the branch is a methyl group at carbon 4 of the five-carbon parent chain.^[ref]

The name makes a useful atom-counting example. A pentanal parent chain supplies five carbons, and the methyl substituent supplies a sixth. The hydrogen count is $1+2+2+1+3+3=12$, including the hydrogen attached to the aldehyde carbon. Five in the parent-chain name does not mean that the entire molecule contains only five carbons.

4-Methylpentanal also provides a chemically identifiable coproduct of cholesterol side-chain cleavage. The cholesterol side-chain cleavage enzyme makes pregnenolone and 4-Methylpentanal, separating the original 27-carbon skeleton into 21- and six-carbon products.^[ref] In an ideal fully coupled reaction, one mole of pregnenolone corresponds to one mole of this aldehyde. Detecting both products can therefore test the proposed material balance more specifically than measuring total steroid-related signal alone.

Adrenodoxin is an iron-sulfur cluster-containing electron-transfer protein involved in mitochondrial steroid synthesis. It transfers reducing equivalents to mitochondrial Cytochrome P450 enzymes, including the cholesterol side-chain cleavage enzyme. Its cluster is of the $[2\mathrm{Fe}-2\mathrm{S}]$ type; the structural presence of that cofactor and its interaction with a partner can be investigated separately from catalytic turnover.^[ref]

The electron-transfer chain distinguishes the donor from the enzyme doing the substrate conversion. NADPH supplies electrons upstream through adrenodoxin reductase; reduced adrenodoxin then supplies one-electron equivalents to the cholesterol side-chain cleavage enzyme.^[ref]

The fully coupled overall reaction uses six reduced adrenodoxin equivalents per pregnenolone. Thus an original ideal bookkeeping example producing $2\mu \mathrm{mol}$ of pregnenolone needs $12\mu \mathrm{mol}$ of one-electron donor equivalents. This does not mean twelve micromoles of fresh protein must be consumed: a carrier can be reduced again and reused.

A 2011 study also changed adrenodoxin conditions while measuring carbon monoxide access to reduced haem spectroscopically. This probes an effect of the redox partner on the catalytic protein, beyond merely locating two structures next to one another.^[ref]

Adrenodoxin reductase is a flavoprotein enzyme that transfers electrons from NADPH to adrenodoxin. Its flavin adenine dinucleotide cofactor links a two-electron donor to a carrier that transfers one electron per reduction. The accepted IUBMB name is adrenodoxin-NADP${}^{+}$ reductase, EC 1.18.1.6.^[ref]

In the NADPH-consuming direction, the electron balance is represented byThe subscripts specify oxidized and reduced adrenodoxin. Two reductions need two electron equivalents, supplied by one NADPH molecule; counting carrier molecules without counting electrons would miss this relation.^[ref]

The reduced carrier can then deliver electrons to a mitochondrial Cytochrome P450, including the cholesterol side-chain cleavage enzyme. That enzyme's net reaction requires six reduced-adrenodoxin equivalents per pregnenolone formed, corresponding ideally to three NADPH equivalents supplied upstream.^[ref]

This separation suggests a useful measurement distinction. Observing NADPH oxidation can establish electron-donor consumption, while detecting pregnenolone establishes a downstream chemical product. The former alone does not demonstrate complete coupling through every stage. Adrenodoxin is recycled as a carrier rather than permanently consumed as six new protein molecules per product.

The cholesterol side-chain cleavage enzyme, also designated CYP11A1, is a Cytochrome P450 that converts cholesterol into pregnenolone and 4-Methylpentanal. Its official accepted name is cholesterol monooxygenase (side-chain-cleaving), EC 1.14.15.6. Two hydroxylations precede cleavage between carbon positions 20 and 22.^[ref]

Adrenodoxin supplies electrons to the enzyme; NADPH is an upstream electron source. For the fully coupled net reaction, each pregnenolone formed requires three oxygen molecules and six reduced adrenodoxins. Thus an ideal $1\mu \mathrm{mol}$ conversion consumes $3\mu \mathrm{mol}$ oxygen and six micromoles of one-electron donor equivalents. The carbon balance is $27=21+6$, partitioning the original steroid and its shortened side chain.^[ref]

In 2011, Natalia Mast and colleagues combined X-ray crystallography with solution spectroscopy. Their $2.5\text{A˚}$ structure contained 22R-Hydroxycholesterol, the first intermediate, whose hydroxyl oxygen lay $2.56\text{A˚}$ from the haem iron. Changing adrenodoxin conditions altered carbon monoxide access to reduced haem in a spectroscopic test.^[ref]

Together, these measurements connect substrate positioning with a perturbation in solution. The proposed movement of intermediates during successive reactions is a mechanistic interpretation of the combined evidence; a single structure is a snapshot of one bound state.

J. Tapanainen is the first author of a 1991 study of steroid production in cultured human granulosa-lutein cells. The team compared 48-hour cultures with and without human chorionic gonadotropin or follicle-stimulating hormone, measuring several steroids and assaying aromatase activity separately.^[ref]

Both hormones increased pregnenolone and progesterone production substantially, while changes in several other steroid products were small. This illustrates why one hormone measurement cannot summarize a whole biochemical pathway: different reaction steps can impose different constraints. Separate measurements of products and enzyme activity make the proposed regulation experimentally testable, while the cultured-cell result remains distinct from a complete account of ovarian function in an animal.^[ref]

Natalia Mast is the first author of a 2011 study explaining how the cholesterol side-chain cleavage enzyme carries out successive reactions converting cholesterol toward pregnenolone. The investigators studied the enzyme bound to the first oxygenated intermediate, combining a crystal structure with solution measurements.^[ref]

The active site forms an elongated cavity leading toward the haem group. The intermediate's placement and interactions suggested that movement within this cavity permits successive reactions while the sterol remains associated with the enzyme. Solution spectroscopy tested changes in its position.^[ref]

The example illustrates why one catalyst can support a multistep transformation without requiring the intermediate to diffuse freely after every step. A bound structure proposes spatial constraints; measurements in solution test whether the arrangement can change, rather than assuming that a crystal captures the only functional position.

Natallia Strushkevich is the first author of a 2011 structural study of the mitochondrial system that converts cholesterol toward pregnenolone. The team examined the cholesterol side-chain cleavage enzyme together with its electron-transfer partner adrenodoxin.^[ref]

An engineered fusion protein helped hold the partners together for crystal structure determination. The structure related the iron-sulfur cluster of adrenodoxin to the haem group of the catalytic protein, while structures with different bound sterols addressed successive reaction stages.^[ref]

The engineered connection was an experimental aid, not evidence that the native proteins form one continuous chain. Comparing fusion proteins with different linker lengths also tested how the imposed connection affected reduction of the catalytic partner.^[ref] The example connects a useful structure-stabilizing intervention to an explicit check on its functional consequences.

Pregnenolone is a 21-carbon steroid with a position-3 beta-oriented hydroxyl group, a position-20 ketone and a double bond between carbon positions 5 and 6. Its molecular formula is ${\mathrm{C}}_{21}{\mathrm{H}}_{32}{\mathrm{O}}_2$.^[ref]

A key early step of steroid hormone synthesis converts cholesterol into pregnenolone. The cholesterol side-chain cleavage enzyme first hydroxylates the substrate at two positions and then cleaves the side chain, producing pregnenolone and 4-Methylpentanal. This is a sequence of oxygen-dependent reactions with electron transfer, not simply spontaneous breaking of a carbon chain.^[ref]

The products illustrate a compact material-balance check. The 27 carbons of cholesterol divide into 21 in pregnenolone and six in the aldehyde product: $27=21+6$. This count alone does not balance oxygen or hydrogen, but it makes clear why a pathway can retain the four-ring steroid framework while shortening its side chain. Identifying pregnenolone in a sample establishes a particular chemical intermediate; its presence alone does not measure the rate of every downstream hormone-producing reaction.